Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2005-09-27 / Cancer Immunol Immunother 2006 Jul;55(7):819-29Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2005-09-01 / Leukemia 2005 Sep;19(9):1621-7Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):496-504Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo
/in Dendritic Cells, International Publications /von 2005-08-23 / Blood 2005 Dec;106(13):4225-33Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
/in Dendritic Cells, Glioblastoma, International Publications /von 2005-08-01 / Clin. Cancer Res. 2005 Aug;11(15):5515-25Natural-killer cells and dendritic cells: „l’union fait la force“
/in Dendritic Cells, International Publications /von 2005-06-02 / Blood 2005 Oct;106(7):2252-8Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2005-06-01 / Clin. Cancer Res. 2005 Jun;11(11):4160-7Chaperone-rich cell lysates, immune activation and tumor vaccination
/in Dendritic Cells, Hyperthermia, International Publications /von 2005-05-11 / Cancer Immunol. Immunother. 2006 Mar;55(3):329-38Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function
/in Dendritic Cells, Hyperthermia, International Publications /von 2005-04-28 / Cancer Immunol. Immunother. 2006 Mar;55(3):292-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de